Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms

被引:54
|
作者
Cocuaud, C [1 ]
Rodier, MH [1 ]
Daniault, G [1 ]
Imbert, C [1 ]
机构
[1] CHU La Miletrie, Lab Parasitol & Mycol Med, F-86021 Poitiers, France
关键词
candidiasis; catheters; antifungals; metabolism; echinocandins;
D O I
10.1093/jac/dki269
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Candidiasis can be associated with the formation of biofilms on bioprosthetic surfaces and the intrinsic resistance of Candida albicans biofilms to the most commonly used antifungal agents has been demonstrated. In this study, we report on the antifungal activity of caspofungin at two different concentrations, on C. albicans and Candida parapsilosis biofilms with different ages of maturation. Methods: Fifteen strains of C. albicans (10 strains susceptible to fluconazole in vitro and five strains resistant to this antifungal agent) and six strains of C. parapsilosis (all were susceptible to fluconazole in vitro) were studied. The antifungal activity of caspofungin was assessed by looking for a significant inhibition of the metabolic activity of yeasts within biofilms. Biofilms of Candida were produced in vitro, on silicone catheters. Results: Caspofungin used at MIC did not modify the metabolic activity of C. albicans, whatever the maturation age of the biofilms. The same concentration of caspofungin significantly reduced the metabolism (P <= 0.001) of 25% (biofilms of 48 h) to 50% (biofilms of 2 h) of the C. parapsilosis yeasts. The use of a therapeutic concentration of caspofungin (2 mg/L) significantly decreased (P <= 0.001) the metabolism of all the strains of C. albicans and C. parapsilosis tested, independently of the biofilm maturation age. This potent antifungal activity of caspofungin on C. albicans biofilms was observed independently of the yeast susceptibility to fluconazole. Conclusions: This study demonstrated that caspofungin used at MIC was not sufficient to reduce C. albicans biofilms, but it suggested an activity on C. parapsilosis biofilms depending on their maturation age. This study also indicated that caspofungin used at 2 mg/L could be a good candidate in the prevention of candidiasis associated with silicone medical devices. Our results also suggested that fluconazole resistance of yeasts did not affect caspofungin activity.
引用
下载
收藏
页码:507 / 512
页数:6
相关论文
共 50 条
  • [31] In vitro activity of eugenol against Candida albicans biofilms
    He, Miao
    Du, Minquan
    Fan, Mingwen
    Bian, Zhuan
    MYCOPATHOLOGIA, 2007, 163 (03) : 137 - 143
  • [32] Pharmacodynamic and Immunomodulatory Effects of Micafungin on Host Responses against Biofilms of Candida parapsilosis in Comparison to Those of Candida albicans
    Simitsopoulou, Maria
    Chlichlia, Katerina
    Kyrpitzi, Daniela
    Walsh, Thomas J.
    Roilides, Emmanuel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (08)
  • [33] Lack of efficacy of echinocandins against high metabolic activity biofilms of Candida parapsilosis clinical isolates
    Thomaz, Danilo Yamamoto
    Carvalho Melhem, Marcia de Souza
    de Almeida Junior, Joao Nobrega
    Benard, Gil
    Barbaro Del Negro, Gilda Maria
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2020, 51 (03) : 1129 - 1133
  • [34] In vitro activity of anidulafungin and amphotericin B combination against Candida glabrata and Candida parapsilosis biofilms
    Valentin, A.
    Canton, E.
    Peman, J.
    Martinez, J. P.
    MYCOSES, 2011, 54 : 161 - 161
  • [35] Lack of efficacy of echinocandins against high metabolic activity biofilms of Candida parapsilosis clinical isolates
    Danilo Yamamoto Thomaz
    Marcia de Souza Carvalho Melhem
    João Nobrega de Almeida Júnior
    Gil Benard
    Gilda Maria Barbaro Del Negro
    Brazilian Journal of Microbiology, 2020, 51 : 1129 - 1133
  • [36] A comparison of biofilms formed by Candida albicans and parapsilosis on bioprosthetic surfaces
    Kuhn, DM
    Chandra, J
    Mukherjee, PK
    Ghannoum, MA
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1195 - 1195
  • [37] Activity of Metal-Azole Complexes Against Biofilms of Candida albicans and Candida glabrata
    Pereira, Livia D.
    Vila, Taissa
    Borba-Santos, Luana P.
    de Souza, Wanderley
    Navarro, Maribel
    Rozental, Sonia
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (14) : 1525 - 1531
  • [38] Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms
    Bezerra, Leandro P.
    Freitas, Cleverson D. T.
    Silva, Ayrles F. B.
    Amaral, Jackson L.
    Neto, Nilton A. S.
    Silva, Rafael G. G.
    Parra, Aura L. C.
    Goldman, Gustavo H.
    Oliveira, Jose T. A.
    Mesquita, Felipe P.
    Souza, Pedro F. N.
    ANTIBIOTICS-BASEL, 2022, 11 (05):
  • [39] In vitro activity of antifungal combinations against Candida albicans biofilms
    Tobudic, Selma
    Kratzer, Christina
    Lassnigg, Andrea
    Graninger, Wolfgang
    Presterl, Elisabeth
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (02) : 271 - 274
  • [40] In Vitro Analyses of Ethanol Activity against Candida albicans Biofilms
    Rane, Hallie S.
    Bernardo, Stella M.
    Walraven, Carla J.
    Lee, Samuel A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4487 - 4489